{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2025,6,30]],"date-time":"2025-06-30T14:05:11Z","timestamp":1751292311977},"reference-count":14,"publisher":"Springer Science and Business Media LLC","content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":[],"published-print":{"date-parts":[[2020,12,11]]},"DOI":"10.7759\/cureus.12029","type":"journal-article","created":{"date-parts":[[2020,12,11]],"date-time":"2020-12-11T16:45:34Z","timestamp":1607705134000},"source":"Crossref","is-referenced-by-count":3,"title":["A Case of Euglycemic Diabetic Ketoacidosis in a Patient With Type 2 Diabetes Mellitus and COVID-19"],"prefix":"10.7759","author":[{"given":"Nathan","family":"Morrison","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Katherine","family":"Barnett","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Julianna","family":"Tantum","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Hannah K","family":"Morrison","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Michael","family":"Whalen","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"297","reference":[{"key":"ref1","doi-asserted-by":"publisher","DOI":"10.15585\/mmwr.mm6712a3","article-title":"Trends in diabetic ketoacidosis hospitalizations and in-hospital mortality - United States, 2000-2014","volume":"67","author":"Benoit SR","year":"2018","unstructured":"Benoit SR, Zhang Y, Geiss LS, Gregg EW, Albright A. Trends in diabetic ketoacidosis hospitalizations and in-hospital mortality - United States, 2000-2014. MMWR Morb Mortal Wkly Rep. 2018, 67:362-365. 10.15585\/mmwr.mm6712a3","journal-title":"MMWR Morb Mortal Wkly Rep"},{"key":"ref2","doi-asserted-by":"publisher","DOI":"10.2337\/dci18-0004","article-title":"Increasing hospitalizations for DKA: a need for prevention programs","volume":"41","author":"Vellanki P","year":"2018","unstructured":"Vellanki P, Umpierrez GE. Increasing hospitalizations for DKA: a need for prevention programs. Diabetes Care. 2018, 41:1839-1841. 10.2337\/dci18-0004","journal-title":"Diabetes Care"},{"key":"ref3","article-title":"Euglycemic diabetic ketoacidosis","author":"Plewa MC","year":"2020","unstructured":"Plewa MC, Bryant M, King-Thiele R. Euglycemic diabetic ketoacidosis. In StatPearls [Internet]. StatPearls Publishing, Treasure Island, FL; 2020."},{"key":"ref4","doi-asserted-by":"publisher","DOI":"10.2337\/dc15-1380","article-title":"Euglycemic diabetic ketoacidosis: a predictable, detectable, and preventable safety concern with SGLT2 inhibitors","volume":"38","author":"Rosenstock J","year":"2015","unstructured":"Rosenstock J, Ferrannini E. Euglycemic diabetic ketoacidosis: a predictable, detectable, and preventable safety concern with SGLT2 inhibitors. Diabetes Care. 2015, 38:1638-1642. 10.2337\/dc15-1380","journal-title":"Diabetes Care"},{"key":"ref5","doi-asserted-by":"publisher","DOI":"10.1056\/NEJMc1600827","article-title":"Empagliflozin, cardiovascular outcomes, and mortality in type 2 diabetes","volume":"374","author":"Zinman B","year":"2016","unstructured":"Zinman B, Lachin JM, Inzucchi SE. Empagliflozin, cardiovascular outcomes, and mortality in type 2 diabetes. N Engl J Med. 2016, 374:1092-1094. 10.1056\/NEJMc1600827","journal-title":"N Engl J Med"},{"key":"ref6","doi-asserted-by":"publisher","DOI":"10.1111\/dom.14057","article-title":"COVID-19 infection may cause ketosis and ketoacidosis","volume":"22","author":"Li J","year":"2020","unstructured":"Li J, Wang X, Chen J, Zuo X, Zhang H, Deng A. COVID-19 infection may cause ketosis and ketoacidosis. Diabetes Obes Metab. 2020, 22:1935-1941. 10.1111\/dom.14057","journal-title":"Diabetes Obes Metab"},{"key":"ref7","doi-asserted-by":"publisher","DOI":"10.1080\/17843286.2020.1780390","article-title":"Euglycemic diabetic ketoacidosis in a patient with type 1 diabetes and SARS-CoV-2 pneumonia: case report and review of the literature. [Online ahead of print]","author":"Oriot P","year":"2020","unstructured":"Oriot P, Hermans MP. Euglycemic diabetic ketoacidosis in a patient with type 1 diabetes and SARS-CoV-2 pneumonia: case report and review of the literature. [Online ahead of print]. Acta Clin Belg. 2020, 1-5. 10.1080\/17843286.2020.1780390","journal-title":"Acta Clin Belg"},{"key":"ref8","doi-asserted-by":"publisher","DOI":"10.1007\/s13340-020-00473-3","article-title":"COVID-19-associated euglycemic diabetic ketoacidosis in a patient with type 2 diabetes on SGLT2 inhibitor: a case report. [Online ahead of print]","author":"Batista DV","year":"2020","unstructured":"Batista DV, Vieira CAFA, Costa TA, Lima EG. COVID-19-associated euglycemic diabetic ketoacidosis in a patient with type 2 diabetes on SGLT2 inhibitor: a case report. [Online ahead of print]. Diabetol Int. 2020, 1-4. 10.1007\/s13340-020-00473-3","journal-title":"Diabetol Int"},{"key":"ref9","doi-asserted-by":"publisher","DOI":"10.1210\/clinem\/dgaa360","article-title":"Diabetic ketoacidosis in COVID-19: unique concerns and considerations","volume":"105","author":"Palermo NE","year":"2020","unstructured":"Palermo NE, Sadhu AR, McDonnell ME. Diabetic ketoacidosis in COVID-19: unique concerns and considerations. J Clin Endocrinol Metab. 2020, 105:2819-2829. 10.1210\/clinem\/dgaa360","journal-title":"J Clin Endocrinol Metab"},{"key":"ref10","doi-asserted-by":"publisher","DOI":"10.1159\/000169069","article-title":"Evaluation of ventilatory responses in severe acidemia in diabetic ketoacidosis","volume":"17","author":"Guh JY","year":"1997","unstructured":"Guh JY, Lai YH, Yu LK, Shin SJ, Tsai JH. Evaluation of ventilatory responses in severe acidemia in diabetic ketoacidosis. Am J Nephrol. 1997, 17:36-41. 10.1159\/000169069","journal-title":"Am J Nephrol"},{"key":"ref11","doi-asserted-by":"publisher","DOI":"10.7326\/0003-4819-105-6-836","article-title":"Bicarbonate therapy in severe diabetic ketoacidosis","volume":"105","author":"Morris LR","year":"1986","unstructured":"Morris LR, Murphy MB, Kitabchi AE. Bicarbonate therapy in severe diabetic ketoacidosis. Ann Intern Med. 1986, 105:836-840. 10.7326\/0003-4819-105-6-836","journal-title":"Ann Intern Med"},{"key":"ref12","doi-asserted-by":"publisher","DOI":"10.1507\/endocrj.ej11-0024","article-title":"Cytokine response to diabetic ketoacidosis (DKA) in children with type 1 diabetes (T1DM)","volume":"58","author":"Karavanaki K","year":"2011","unstructured":"Karavanaki K, Karanika E, Georga S, et al.. Cytokine response to diabetic ketoacidosis (DKA) in children with type 1 diabetes (T1DM). Endocr J. 2011, 58:1045-1053. 10.1507\/endocrj.ej11-0024","journal-title":"Endocr J"},{"key":"ref13","doi-asserted-by":"publisher","DOI":"10.2337\/diabetes.51.12.3391","article-title":"Interleukin-6 induces cellular insulin resistance in hepatocytes","volume":"51","author":"Senn JJ","year":"2002","unstructured":"Senn JJ, Klover PJ, Nowak IA, Mooney RA. Interleukin-6 induces cellular insulin resistance in hepatocytes. Diabetes. 2002, 51:3391-3399. 10.2337\/diabetes.51.12.3391","journal-title":"Diabetes"},{"key":"ref14","doi-asserted-by":"publisher","DOI":"10.1093\/cid\/ciaa449","article-title":"Detectable serum severe acute respiratory syndrome coronavirus 2 viral load (RNAemia) is closely correlated with drastically elevated interleukin 6 level in critically ill patients with coronavirus disease 2019","volume":"71","author":"Chen X","year":"2020","unstructured":"Chen X, Zhao B, Qu Y, et al.. Detectable serum severe acute respiratory syndrome coronavirus 2 viral load (RNAemia) is closely correlated with drastically elevated interleukin 6 level in critically ill patients with coronavirus disease 2019. Clin Infect Dis. 2020, 71:1937-1942. 10.1093\/cid\/ciaa449","journal-title":"Clin Infect Dis"}],"container-title":["Cureus"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/www.cureus.com\/articles\/46863-a-case-of-euglycemic-diabetic-ketoacidosis-in-a-patient-with-type-2-diabetes-mellitus-and-covid-19","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2024,2,9]],"date-time":"2024-02-09T19:21:39Z","timestamp":1707506499000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.cureus.com\/articles\/46863-a-case-of-euglycemic-diabetic-ketoacidosis-in-a-patient-with-type-2-diabetes-mellitus-and-covid-19"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2020,12,11]]},"references-count":14,"URL":"https:\/\/doi.org\/10.7759\/cureus.12029","relation":{},"ISSN":["2168-8184"],"issn-type":[{"value":"2168-8184","type":"print"}],"subject":[],"published":{"date-parts":[[2020,12,11]]}}}